Relation of tumor pathologic and molecular features to outcome after surgical resection of localized primary gastrointestinal stromal tumor (GIST): Results of the intergroup phase III trial ACOSOG Z9001 C. L. Corless, K. V. Ballman, C. Antonescu, C. Blanke, M. E. Blackstein, G. D. Demetri, M. von Mehren, R. G. Maki, P. W. T. Pisters, R. P. DeMatteo American College of Surgeons Oncology Group (ACOSOG) Intergroup Adjuvant GIST Study Team Oregon Health & Science Univ, Portland, OR; University of Toronto, Toronto, ON; Mayo Clinic, Rochester, MN; University of British Columbia/British Columbia Cancer Agency, Vancouver, BC; Dana Farber Cancer Inst, Boston, MA; Fox Chase Cancer Ctr, Philadelphia, PA; UT MD Anderson Cancer Ctr, Houston, TX; Memorial Sloan-Kettering Cancer Center, New York, NY
19
Embed
Relation of tumor pathologic and molecular features to outcome after surgical resection of localized primary gastrointestinal stromal tumor (GIST): Results.
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Relation of tumor pathologic and molecular features to outcome after surgical resection of localized primary gastrointestinal stromal tumor (GIST): Results of the
intergroup phase III trial ACOSOG Z9001
C. L. Corless, K. V. Ballman, C. Antonescu, C. Blanke, M. E. Blackstein, G. D. Demetri, M. von Mehren, R. G. Maki, P. W. T. Pisters, R. P. DeMatteo
American College of Surgeons Oncology Group (ACOSOG) Intergroup Adjuvant GIST Study Team
Oregon Health & Science Univ, Portland, OR; University of Toronto, Toronto, ON; Mayo Clinic, Rochester, MN; University of British Columbia/British Columbia Cancer Agency, Vancouver, BC; Dana Farber Cancer Inst, Boston, MA; Fox Chase Cancer Ctr, Philadelphia, PA; UT MD Anderson Cancer Ctr, Houston, TX; Memorial Sloan-Kettering Cancer Center, New York, NY